可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Reaven GM. Banting lecture: Role of insulin resistance in human disease[J ]. Diabetes, 1998, 87: 1595.
[2] 李光伟, 潘孝仁. 检测人群胰岛素敏感性的一项新指数[J ]. 中华内科杂志, 1993, 10: 656.
[3] 俞茂华, 钟学礼. 肥胖症[M ]. 见: 戴自英. 实用内科学[M ].上册. 第9 版. 北京: 人民卫生出版社, 1993: 667~ 672.
[4] Walton C, Godslanel IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, section and clearance in nonobese healthy man[J ]. J Clin Endocrinol Metab, 1992, 75: 17.
[5] Schnerier DJ , Nordt TK, Ferrannin E, et al. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients[J ]. Diabetes, 1993, 42: 1.
[6] Landin K, Tengborn L , Smith U. Elevated fibrinogen and plasminoge activator inhibitor (PA I21 ) in hypertension are related to metabolic risk factors for cardiovasular disease[J ]. J Intern Med , 1990, 227 (4) : 273.
[7] Bavenholm P, Proudler A , Silveria A , et al. Relationships of insulin and intact and split proinsulin to haemostatic function in young man with and without coronary artery disease [J ]. Thromb Haemost, 1995, 73: 568.